Filament has been issued the first patent for the extraction and standardization of natural psilocybin and intends to further develop its IP portfolio Vancouver, British Columbia, September 1, 2021 – Filament Health Corp. (NEO:FH) (“Filament” or the “Company”), a leading exclusively-natural psychedelic drug development company, today announced that it has filed its 20th patent application in…
